Destiny Pharma PLC
LSE:DEST
Destiny Pharma PLC
LSE:DEST
Price:
3
GBX
-25%
Market Closed
Market Cap:
£2.9m
Balance Sheet
Balance Sheet Decomposition
Destiny Pharma PLC
Destiny Pharma PLC
Balance Sheet Decomposition is not available for
Destiny Pharma PLC
Destiny Pharma PLC
Balance Sheet
Destiny Pharma PLC
Destiny Pharma PLC
Currency: GBP
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
2
|
1
|
1
|
12
|
7
|
7
|
10
|
5
|
5
|
3
|
|
| Cash |
2
|
1
|
1
|
12
|
7
|
7
|
10
|
5
|
2
|
3
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
5
|
5
|
0
|
0
|
0
|
0
|
4
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Total Current Assets |
2
|
1
|
2
|
17
|
13
|
9
|
11
|
6
|
7
|
8
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
|
| Total Assets |
2
N/A
|
1
-45%
|
2
+26%
|
17
+905%
|
13
-24%
|
9
-34%
|
14
+60%
|
8
-40%
|
9
+6%
|
10
+13%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
-79%
|
0
+64%
|
0
+157%
|
1
+102%
|
1
0%
|
1
+59%
|
1
-39%
|
1
+51%
|
1
-34%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Retained Earnings |
15
|
16
|
17
|
1
|
5
|
10
|
15
|
20
|
26
|
31
|
|
| Additional Paid In Capital |
17
|
17
|
18
|
17
|
17
|
17
|
27
|
27
|
33
|
40
|
|
| Total Equity |
2
N/A
|
1
-37%
|
2
+23%
|
17
+980%
|
12
-27%
|
8
-37%
|
12
+60%
|
8
-40%
|
8
+2%
|
9
+20%
|
|
| Total Liabilities & Equity |
2
N/A
|
1
-45%
|
2
+26%
|
17
+905%
|
13
-24%
|
9
-34%
|
14
+60%
|
8
-40%
|
9
+6%
|
10
+13%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
42
|
42
|
42
|
44
|
44
|
44
|
60
|
60
|
73
|
95
|
|
Switch to:
Switch to:
See Also
Discover More
